🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 162 of 200 · A–Z by INN

  1. rotigotine

    NEUPRO

    TRANSDERMAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    N04BC09

  2. roxadustat

    EVRENZO

    EMA: approved · PMDA: approved · NMPA: clinical trials

    B03XA05

  3. roxithromycin

    ROXAR 300 Apotex Pty Ltd

    TGA: approved

  4. rozanolixizumab

    RYSTIGGO

    EMA: approved

    L04AL02

  5. rozanolixizumab-noli

    RYSTIGGO

    SUBCUTANEOUS FDA: approved

  6. rt-pa

    NMPA: clinical trials

  7. rtv

    NMPA: clinical trials

  8. rubidium chloride rb-82

    RUBY-FILL

    INJECTION FDA: approved

  9. rubitecan

    ORATHECIN

    EMA: application withdrawn

  10. ruboxistaurin

    ARXXANT

    EMA: application withdrawn

  11. rucaparib

    RUBRACA

    EMA: approved

    L01XX

  12. rucaparib camsylate

    RUBRACA

    ORAL FDA: approved

  13. rufinamide

    INOVELON

    ORAL FDA: approved · EMA: approved

    N03AF03

  14. rurioctocog alfa pegol

    ADYNOVI

    EMA: approved · PMDA: approved

    B02BD02

  15. ruxolitinib

    JAKAVI Novartis Pharmaceuticals

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    D11AH

  16. ruxolitinib phosphate

    JAKAFI XR

    TOPICAL FDA: approved

  17. s-1

    NMPA: clinical trials

  18. s-ketamine

    NMPA: clinical trials

  19. s1

    NMPA: clinical trials

  20. sacituzumab

    NMPA: clinical trials

  21. sacituzumab govitecan

    TRODELVY Gilead Sciences Pty Limited

    EMA: approved · TGA: approved

    L01FX06

  22. sacituzumab govitecan-hziy

    TRODELVY

    INJECTION FDA: approved

  23. sacrosidase

    SUCRAID

    ORAL FDA: approved

  24. sacubitril

    ENTRESTO

    ORAL FDA: approved · EMA: approved

    C09DX04

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources